对COVID-19表型通信的回应
本文回应了Cherian等人对COVID-19呼吸生理学解读的质疑,指出低呼吸系统顺应性已在超过800例COVID-19患者中得到广泛证实,包括与非COVID-19 ARDS的直接比较未显示顺应性差异;而对方引用的三个病例系列样本量小且报告的顺应性均值仍属异常。
要点
- COVID-19患者低呼吸系统顺应性已被超过800例患者的研究广泛证实。
- 与非COVID-19 ARDS患者直接比较未显示呼吸系统顺应性差异。
- 对方引用的病例系列样本量小且报告的顺应性均值仍属异常。
核心结论
- COVID-19相关ARDS的表型分析应采用严谨的数据驱动方法,低呼吸系统顺应性已被大量研究证实。
研究设计与样本
- 本文为对通信的回应,引用多项研究共超过800例COVID-19患者,包括与非COVID-19 ARDS的直接比较。
主要发现
- 超过800例COVID-19患者的研究广泛证实低呼吸系统顺应性。
- 与非COVID-19 ARDS患者直接比较未显示呼吸系统顺应性差异。
- 对方引用的三个病例系列样本量分别为16、10和26例。
- 这些病例系列报告的COVID-19平均呼吸系统顺应性为40–45 mL·cmH2O−1,属异常且远非近正常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Phenotyping of COVID-19-related ARDS should be done using careful, data-driven approaches https://bit.ly/3eX65Yu In their letter, R. Cherian and co-workers take issue with our interpretation of the respiratory physiology of coronavirus disease 2019 (COVID-19), arguing that it is based merely on “small cohort studies”, and instead declaring that “a high proportion of mechanically ventilated COVID-19 patients exhibit near-normal lung compliance”. Yet the low respiratory compliance of COVID-19 patients has now been extensively demonstrated by studies totalling more than 800 COVID-19 patients [1–7], including a direct comparison with non-COVID-19 acute respiratory distress syndrome (ARDS) patients that revealed no difference in respiratory compliance [7]. In contrast, the three case series cited by R. Cherian and co-workers in support of their claim comprise cohorts of, respectively, 16, 10 and 26 patients [8–10]. Furthermore, even these case series report average respiratory compliance in COVID-19 of 40–45 mL·cmH2O−1, which is in fact abnormal and far from “near-normal compliance” [11, 12].
引用
- Bos LDJ, Sinha P, Dickson RP, et al. Response to COVID-19 phenotyping correspondence. Eur Respir J. 2020. PMID: 32747393. doi:10.1183/13993003.02756-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。